Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer᾽s Disease
Authors
Abstract:
Different treatment strategies of Alzheimer's disease (AD) are being studied for treating or slowing the progression of AD. Many pharmaceutically important regulation systems operate through proteins as drug targets. Here, we investigate the drug target proteins in beta-amyloid (Aβ) injected rat hippocampus treated with Lavandula angustifolia (LA) by proteomics techniques. The reported study showed that lavender extract (LE) improves the spatial performance in AD animalmodel by diminishing Aβ production in histopathology of hippocampus, so in this study neuroprotective proteins expressed in Aβ injected rats treated with LE were scrutinized. Rats were divided into three groups including normal, Aβ injected, and Aβ injected that was treated with LE. Protein expression profiles of hippocampus tissue were determined by two-dimensional electrophoresis (2DE) method and dysregulated proteins such as Snca, NF-L, Hspa5, Prdx2, Apoa1, and Atp5a1were identified by MALDI-TOF/TOF. KEGG pathway and gene ontology (GO) categories were used by searching DAVID Bioinformatics Resources. All detected protein spots were used to determine predictedinteractions with other proteins in STRING online database. Different isoforms of important protein, Snca that exhibited neuroprotective effects by anti-apoptotic properties were expressed. NF-L involved in themaintenance of neuronal caliber. Hspa5 likewise Prdx2 displays as anti-apoptotic protein that Prdx2 also involved in the neurotrophic effects. Apoa1 has anti-inflammatory activity and Atp5a1, produces ATP from ADP. To sum up, these proteins as potential drug targets were expressed in hippocampus in response to effective components in LA may have therapeutic properties for the treatment of AD and other neurodegenerative diseases.
similar resources
protein drug targets of lavandula angustifolia on treatment of rat alzheimer᾽s disease
different treatment strategies of alzheimer's disease (ad) are being studied for treating or slowing the progression of ad. many pharmaceutically important regulation systems operate through proteins as drug targets. here, we investigate the drug target proteins in beta-amyloid (aβ) injected rat hippocampus treated with lavandula angustifolia (la) by proteomics techniques. the reported stu...
full textProtein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease
Different treatment strategies of Alzheimer's disease (AD) are being studied for treating or slowing the progression of AD. Many pharmaceutically important regulation systems operate through proteins as drug targets. Here, we investigate the drug target proteins in beta-amyloid (Aβ) injected rat hippocampus treated with Lavandula angustifolia (LA) by proteomics techniques. The reported study sh...
full textFuture drug treatment in Alzheimer ́ s disease
Cumulative evidence shows that progressive cerebral deposition of beta-amyloid peptide (Abeta seems to plays a seminal role in the pathogenesis of Alzheimer’s disease (AD) [1, 2]. There is great interest, therefore, in understanding the proteolytic processing of amyloid presursur protein (APP) and its proteases responsible for cleaving at the aminoand carboxy-terminals of the A region. The ca...
full textAssessment report on Lavandula angustifolia Miller, aetheroleum and Lavandula angustifolia Miller, flos
ion made from these limitations and weaknesses, independently from the form administered, lavender oil seems to positively influence anxiety and stress-related restlessness. However, the peroral use of lavender oil cannot be accepted as well-established use, as the essential factors to be taken into account in order to establish a well-established medicinal use (according to Annex I of Directiv...
full textP156: Effect of Air Pollution on Alzheimer\'s Disease
Alzheimer, a chronic neurodegenerative disease, usually starts slowly and worsens gradually. It causes 60% to 70% of dementia cases. Difficulty in remembering recent events (short-term memory loss) is the most prominent early symptom. As the disease progresses, patients may have problems such as impaired language, disorientation (including easily getting lost), mood swings, loss of motivation, ...
full textMy Resources
Journal title
volume 14 issue 1
pages 291- 302
publication date 2015-01-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023